Biocon shares rise 1.4% after 10-year Pertuzumab partnership in Brazil

·1h ago
Share:PostShare

Pertuzumab is an antibody used to treat HER2-positive breast cancer and is currently not manufactured locally in Brazil.

M

Moneycontrol

Original source

Read full story

biocon biologics

Check live status on DownRightNow

Check status →

Related Stories

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer